# A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.

> **NCT00078000** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 64 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** SU011248

## Key facts

- **NCT ID:** NCT00078000
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2008-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00078000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00078000, "A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00078000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*